Our products

CNX Therapeutics commercialise and distribute a portfolio of speciality brands and hospital products in over 40 countries worldwide, both directly and through strategic partnerships. These products cover a range of therapeutic areas including CNS, oncology and critical care.

We are seeking to expand our product portfolio and are open to in-licensing, co-promotion, revenue-sharing, and other partnering opportunities.

Please also reach out to us to discuss out-licensing opportunities available for global commercialisation.